{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:43:33Z","timestamp":1762004613874},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2431-14-203","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T13:24:57Z","timestamp":1408022697000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Newborn screening for pompe disease? a qualitative study exploring professional views"],"prefix":"10.1186","volume":"14","author":[{"given":"Carla G","family":"van El","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessel","family":"Rigter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold JJ","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans T","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie S","family":"Weinreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina C","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"1134_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10545-012-9484-z","volume":"35","author":"P Burgard","year":"2012","unstructured":"Burgard P, Rupp K, Lindner M, Haege G, Rigter T, Weinreich SS, Loeber JG, Taruscio D, Vittozzi L, Cornel MC, Hoffmann GF: Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2 - from screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis. 2012, 35: 613-625.","journal-title":"J Inherit Metab Dis"},{"key":"1134_CR2","volume-title":"Principles and practice of screening for disease","author":"JMG Wilson","year":"1968","unstructured":"Wilson JMG, Jungner G: Principles and practice of screening for disease. 1968, Geneva: WHO"},{"key":"1134_CR3","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1542\/peds.2007-2222","volume":"122","author":"YH Chien","year":"2008","unstructured":"Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, Chen CA, Wu MH, Huang PH, Tsai FJ, Chen YT, Hwu WL: Early detection of pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics. 2008, 122: e39-e45.","journal-title":"Pediatrics"},{"key":"1134_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","volume":"379","author":"TP Mechtler","year":"2012","unstructured":"Mechtler TP, Stary S, Metz TF, De Jes\u00fas VR, Greber-Platze S, Pollak A, Herkner KR, Streubel B, Kasper DC: Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet. 2012, 379: 335-341.","journal-title":"Lancet"},{"key":"1134_CR5","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1373\/clinchem.2010.152009","volume":"56","author":"TA Duffey","year":"2010","unstructured":"Duffey TA, Bellamy G, Elliott S, Fox AC, Glass M, Turecek F, Gelb MH, Scott CR: A tandem mass spectrometry triplex assay for the detection of fabry, pompe, and mucopolysaccharidosis-I (hurler). Clin Chem. 2010, 56: 1854-1861.","journal-title":"Clin Chem"},{"key":"1134_CR6","unstructured":"Secretary\u2019s Discretionary Advisory Committee for Heritable Disorders in Newborns and Children (DACHDNC): External evidence review report. [ http:\/\/www.hrsa.gov\/advisorycommittees\/mchbadvisory\/heritabledisorders\/nominatecondition\/workgroup.html ]. (Accessed December 11, 2013),"},{"key":"1134_CR7","unstructured":"Genetic Alliance: Federal advisory committee recommends pompe disease for newborn screening. [ http:\/\/www.babysfirsttest.org\/sites\/default\/files\/Pompe_Final_0.pdf ]. (Accessed December 11 2013),"},{"key":"1134_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ejhg.2013.90","volume":"22","author":"MC Cornel","year":"2014","unstructured":"Cornel MC, Rigter T, Weinreich SS, Burgard P, Hoffmann GF, Lindner M, Loeber JG, Rupp K, Taruscio D, Vittozzi L: A framework to start the debate on neonatal screening policies in the EU - an expert opinion document. Eur J Hum Genet. 2014, 22: 12-17.","journal-title":"Eur J Hum Genet"},{"key":"1134_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ajmg.a.35662","volume":"Part A 161A","author":"D G\u00fcng\u00f6r","year":"2013","unstructured":"G\u00fcng\u00f6r D, Reuser AJJ: How to describe the clinical spectrum in pompe disease ?. Am J Med Genet. 2013, Part A 161A: 399-400.","journal-title":"Am J Med Genet"},{"key":"1134_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ejhg.2010.13","volume":"18","author":"Y Bombard","year":"2010","unstructured":"Bombard Y, Miller FA, Hayeems RZ, Avard D, Knoppers BM: Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet. 2010, 18: 751-760.","journal-title":"Eur J Hum Genet"},{"key":"1134_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12687-012-0118-9","volume":"4","author":"J Forman","year":"2013","unstructured":"Forman J, Coyle F, Levy-Fisch J, Roberts P, Terry S, Legge M: Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening. J Community Genet. 2013, 4: 59-67.","journal-title":"J Community Genet"},{"key":"1134_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1057\/palgrave.jphp.3200161","volume":"29","author":"BK Potter","year":"2008","unstructured":"Potter BK, Avard D, Wilson BJ: Newborn blood spot screening in four countries: stakeholder involvement. J Public Health Policy. 2008, 29: 121-142.","journal-title":"J Public Health Policy"},{"key":"1134_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1503\/cmaj.071656","volume":"179","author":"RA Bruni","year":"2008","unstructured":"Bruni RA, Laupacis A, Martin DK for the University of Toronto Priority Setting in Health Care Research Group: Public engagement in setting priorities in health care. CMAJ. 2008, 179: 15-18.","journal-title":"CMAJ"},{"key":"1134_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1172-7-15","volume":"7","author":"SS Weinreich","year":"2012","unstructured":"Weinreich SS, Rigter T, Van El CG, Dondorp WJ, Kostense PJ, Van der Ploeg AT, Reuser AJ, Cornel MC, Hagemans ML: Public support for neonatal screening for pompe disease, a broad-phenotype condition. Orphanet J Rare Dis. 2012, 7: 15-","journal-title":"Orphanet J Rare Dis"},{"key":"1134_CR15","first-page":"11","volume-title":"Neonatal screening","author":"Health Council of the Netherlands","year":"2005","unstructured":"Health Council of the Netherlands: Neonatal screening. 2005, The Hague: Health Council of the Netherlands, 11-"},{"key":"1134_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM Van den Hout","year":"2003","unstructured":"Van den Hout HM, Hop W, Van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, Van der Ploeg AT: The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003, 112: 332-340.","journal-title":"Pediatrics"},{"key":"1134_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ymgme.2012.09.017","volume":"107","author":"T Rigter","year":"2012","unstructured":"Rigter T, Weinreich SS, Van El CG, De Vries JM, Van Gelder CM, G\u00fcng\u00f6r D, Reuser AJ, Hagemans ML, Cornel MC, van der Ploeg AT: Severely impaired health status at diagnosis of pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening. Molecular Genet Metab. 2012, 107: 448-455.","journal-title":"Molecular Genet Metab"},{"key":"1134_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1212\/WNL.0b013e318228c15f","volume":"77","author":"JM Kwon","year":"2011","unstructured":"Kwon JM, Steiner RD: \" I\u2019m fine; I\u2019m just waiting for my disease\". the new and growing class of presymptomatic patients. Neurology. 2011, 77: 522-523.","journal-title":"Neurology"},{"key":"1134_CR19","unstructured":"Health Care Insurance Board of the Netherlands: Advice alglucosidase Alfa (myozyme) in case of pompe disease. (in Dutch) [ http:\/\/www.zorginstituutnederland.nl\/binaries\/content\/documents\/zinl-www\/documenten\/publicaties\/rapporten-en-standpunten\/2012\/1211-advies-alglucosidase-alfa-myozyme-bij-de-indicatie-ziekte-van-pompe\/1211-advies-alglucosidase-alfa-myozyme-bij-de-indicatie-ziekte-van-pompe\/Advies+alglucosidase+alfa+%28Myozyme%29+bij+de+indicatie+%27ziekte+van+Pompe%27.pdf ]. (Acccessed August 2014),"},{"key":"1134_CR20","unstructured":"Schippers EI: Letter from the minister of health, welfare and sports to the house of representatives of the Netherlands on reimbursement for orphan drugs for pompe disease and fabry disease. dated 30-1-2013, reference number GMT-3152045 (in Dutch) [ http:\/\/www.rijksoverheid.nl\/documenten-en-publicaties\/kamerstukken\/2013\/01\/30\/kamerbrief-over-vergoeding-weesgeneesmiddelen-voor-ziekte-van-pompe-en-ziekte-van-fabry.html ]. (Acccessed August 2014),"},{"key":"1134_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12687-011-0063-z","volume":"3","author":"CG Van El","year":"2012","unstructured":"Van El CG, Pieters T, Cornel M: Genetic screening and democracy: lessons from debating genetic screening criteria in the Netherlands. J Community Genet. 2012, 3: 79-89.","journal-title":"J Community Genet"},{"key":"1134_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT Van der Ploeg","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, Van Capelle CI, Van der Beek NA, Wasserstein M, Zivkovic SA: A randomized study of alglucosidasealfa in late-onset Pompe\u2019s disease. N Engl J Med. 2010, 362: 1396-1406.","journal-title":"N Engl J Med"},{"key":"1134_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ejhg.2009.25","volume":"17","author":"P Borry","year":"2009","unstructured":"Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K: Genetic testing in asymptomatic minors: background considerations towards ESHG recommendations. Eur J Hum Genet. 2009, 17: 711-719.","journal-title":"Eur J Hum Genet"},{"key":"1134_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10545-011-9435-0","volume":"35","author":"L Friedman Ross","year":"2012","unstructured":"Friedman Ross L: Newborn screening for lysosomal storage diseases: an ethical and policy analysis. J Inherit Metab Dis. 2012, 35: 627-634.","journal-title":"J Inherit Metab Dis"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-14-203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-14-203\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-14-203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:12:18Z","timestamp":1468368738000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-14-203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-14-203","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]},"article-number":"203"}}